Syntactx

New York, United States Founded: 2010 • Age: 16 yrs Acquired By NAMSA
CRO that assists medical device, pharmaceutical, and diagnostic laboratory companies with the design and execution of clinical research trials.

About Syntactx

Syntactx is a company based in New York (United States) founded in 2010 was acquired by NAMSA in January 2021.. Syntactx offers products and services including Consulting Services, Preclinical Research, Clinical Research, and Medical Device Testing. Syntactx operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $511.85 K (USD), Grant

    Jun 01, 2020

  • Investors
    NAMSA

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    NAMSA

    (Jan 05, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Syntactx

Syntactx offers a comprehensive portfolio of products and services, including Consulting Services, Preclinical Research, Clinical Research, and Medical Device Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides regulatory and market strategies for medical devices

Conducts GLP studies and pathology for device safety

Manages trials and data for medical device efficacy

Performs biocompatibility and sterility tests on devices

People of Syntactx
Headcount 50-200
Employee Profiles 11
Employee Profiles
People
Elizabeth Evans
Manager, Business Development
People
Silas Mann
Data Scientist
People
Michael Murray
Director of Business Development
People
Roseann White, MA
Senior Principal Biostatistician

Unlock access to complete

Funding Insights of Syntactx

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $511,848
  • First Round

    (01 Jun 2020)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2020 Amount Grant - Syntactx Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Syntactx

Syntactx has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NAMSA and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Providing contract manufacturing services
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Syntactx

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Syntactx

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Syntactx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Syntactx

Syntactx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapies for cancer and inflammatory diseases are developed.
domain founded_year HQ Location
CRO clinical development services are provided by Syneos Health.
domain founded_year HQ Location
Full-service CRO expertise in influenza and oncology research is offered.
domain founded_year HQ Location
Outsourced contract research organization services are provided to clients.
domain founded_year HQ Location
Full-service clinical research organization services are provided globally by Parexel.
domain founded_year HQ Location
Global full-service CRO services are delivered in over 80 countries.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Syntactx

Frequently Asked Questions about Syntactx

When was Syntactx founded?

Syntactx was founded in 2010 and raised its 1st funding round 10 years after it was founded.

Where is Syntactx located?

Syntactx is headquartered in New York, United States. It is registered at New York, New York, United States.

What does Syntactx do?

Syntactx was founded in 2010 and is headquartered in New York, United States. As a contract research organization, services are provided to medical device, pharmaceutical, and diagnostic laboratory companies. Focus is placed on the design and execution of clinical research trials. Operations support various stages of trial management within the healthcare sector, ensuring compliance and efficiency in research processes.

Who are the top competitors of Syntactx?

Syntactx's top competitors include Emmes, Syneos Health and ClinChoice.

What products or services does Syntactx offer?

Syntactx offers Consulting Services, Preclinical Research, Clinical Research, and Medical Device Testing.

Who are Syntactx's investors?

Syntactx has 2 investors. Key investors include NAMSA, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available